Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Seeking supplemental FDA funds

Executive Summary

Even before Congress completes the fiscal 2008 appropriations process in September, the FDA Alliance is trying to draw congressional attention to FDA as a potential recipient of more money when a supplemental war funding bill is considered this fall. This funding mechanism could be justified based on the need for additional dollars to pay for capital projects or for new responsibilities stemming from FDA reform legislation, Alliance President Steven Grossman suggests. Whether or not the effort ultimately is successful, it will provide "a continuing reminder that FDA matters every day and that a short budget is not the way to solve the [agency's] problems." The alliance, whose members include industry, consumer and patient advocacy groups, is devoted to gaining more resources for FDA (1"The Pink Sheet" July 16, 2007, p. 16)...
Advertisement

Related Content

Advertisement
UsernamePublicRestriction

Register

PS048754

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel